KR890016966A - 신규 항바이러스제 - Google Patents

신규 항바이러스제 Download PDF

Info

Publication number
KR890016966A
KR890016966A KR1019890006392A KR890006392A KR890016966A KR 890016966 A KR890016966 A KR 890016966A KR 1019890006392 A KR1019890006392 A KR 1019890006392A KR 890006392 A KR890006392 A KR 890006392A KR 890016966 A KR890016966 A KR 890016966A
Authority
KR
South Korea
Prior art keywords
antiviral agents
new antiviral
acetyl
antiviral agent
acceptable salt
Prior art date
Application number
KR1019890006392A
Other languages
English (en)
Other versions
KR970005326B1 (ko
Inventor
이사오 스다
히로시 오오루이
히로시 메구로
다쓰오 이도오
Original Assignee
곤도오 야스노리
메꾸또 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 곤도오 야스노리, 메꾸또 가부시끼가이샤 filed Critical 곤도오 야스노리
Publication of KR890016966A publication Critical patent/KR890016966A/ko
Application granted granted Critical
Publication of KR970005326B1 publication Critical patent/KR970005326B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Abstract

내용 없음

Description

신규 항바이러스제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 N-아세틸-3-플루오로뉴라민산의 억제패턴을 보여주는 딕슨 플롯이다.

Claims (3)

  1. 다음식(I)의 N-아세틸-3-플루오로뉴라민산 또는 그의 약리적으로 허용가능한 염을 포함하는 항바이러스제.
  2. 제 1 항에 있어서, 상기 N-아세틸-3-플루오로뉴라민산이 1㎍ 내지 10mg의 양으로 함유되는 것을 특징으로 하는 항바이러스제.
  3. 제 1 항에 있어서, 주사제, 흡입제 또는 경구 투여제의 형태인 것을 특징으로 하는 항 바이러스제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890006392A 1988-05-13 1989-05-13 신규 항바이러스제 KR970005326B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63-116500 1988-05-13
JP63116500A JPH01287029A (ja) 1988-05-13 1988-05-13 新規抗ウィルス剤

Publications (2)

Publication Number Publication Date
KR890016966A true KR890016966A (ko) 1989-12-14
KR970005326B1 KR970005326B1 (ko) 1997-04-15

Family

ID=14688671

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890006392A KR970005326B1 (ko) 1988-05-13 1989-05-13 신규 항바이러스제

Country Status (9)

Country Link
EP (1) EP0341735B1 (ko)
JP (1) JPH01287029A (ko)
KR (1) KR970005326B1 (ko)
AT (1) ATE81009T1 (ko)
AU (1) AU624138B2 (ko)
DE (1) DE68903031T2 (ko)
DK (1) DK232989A (ko)
IL (1) IL90271A (ko)
NZ (1) NZ229128A (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
EP3149037A4 (en) 2014-05-27 2018-01-10 Academia Sinica Anti-her2 glycoantibodies and uses thereof
KR20220151036A (ko) 2014-05-27 2022-11-11 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
KR20230033737A (ko) 2014-05-27 2023-03-08 아카데미아 시니카 증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-ｔｎｆ-알파 글리코항체 및 이의 용도
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｎ−グリカンおよびそのアレイのモジュール合成のための方法
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2573594B2 (ja) * 1987-03-06 1997-01-22 メクト株式会社 Ｎーアセチルー３ーフルオローノイラミン酸誘導体およびその製造方法

Also Published As

Publication number Publication date
AU3479889A (en) 1989-11-16
AU624138B2 (en) 1992-06-04
IL90271A0 (en) 1989-12-15
ATE81009T1 (de) 1992-10-15
JPH01287029A (ja) 1989-11-17
IL90271A (en) 1994-04-12
DK232989A (da) 1989-11-14
DE68903031T2 (de) 1993-02-18
DE68903031D1 (de) 1992-11-05
KR970005326B1 (ko) 1997-04-15
EP0341735A1 (en) 1989-11-15
DK232989D0 (da) 1989-05-12
EP0341735B1 (en) 1992-09-30
NZ229128A (en) 1991-05-28

Similar Documents

Publication Publication Date Title
KR890016966A (ko) 신규 항바이러스제
KR890701562A (ko) 면역조절 아자스 피란류
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
DE69415445T2 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
KR970025615A (ko) 암 전이 억제제
KR940021059A (ko) 지질 대사 개선제
ATE168562T1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
KR960007592A (ko) 신규한 피롤로카바졸
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
KR910004191A (ko) 신질환치료제
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
KR880009654A (ko) 아세트알데히드의 독성을 감소시키는 조성물 및 방법
ATE40127T1 (de) 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel.
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR890012652A (ko) 소화성 궤양 질환을 치료하기 위한 치료학적 제제
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
KR950032194A (ko) 신규푸린유도체 및 그 약학적으로 허용되는 염
KR960703843A (ko) 아실페닐글리신 유도체 및 그 화합물을 유효성분으로 하는, 콜라게나제 활성증진에 기인한 질환의 예방 및 치료 제(acylphenylglycine derivative and preventive and remedy for diseases caused by increased collagenase activity containing said compound as active ingredient)
KR910015301A (ko) 수면 무호흡증의 치료방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee